ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $376,000 | -0.5% | 6,030 | +32.2% | 0.02% | +5.0% |
| Q2 2021 | $378,000 | -92.9% | 4,562 | -94.6% | 0.02% | -73.3% |
| Q4 2019 | $5,310,000 | +1346.9% | 83,709 | +505.0% | 0.08% | +971.4% |
| Q2 2019 | $367,000 | +86.3% | 13,836 | -12.7% | 0.01% | +75.0% |
| Q4 2018 | $197,000 | – | 15,848 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
| Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
| Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
| ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
| Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
| Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
| Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
| Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
| OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |